BioNTech SE (BNTX) vs Lufax Holding Ltd (LU)
LU leads on 7 of 10 compared metrics.
A side-by-side comparison of BioNTech SE and Lufax Holding Ltd across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — BNTX vs LU
growth of $100 · last 6yBNTX +6.1%LU -97.4%BNTX compounded faster
Log scale — wide-divergence pair
BNTX LU
BNTX vs LU: by the numbers
- •BNTX is the larger company ($22.90B vs $558M market cap).
- •Both run net losses; LU's is the smaller (-10.59% vs -44.73% net margin).
- •BNTX grew revenue faster over the past five years (2.16% vs -6.44% CAGR).
Which is better, BNTX or LU?
Metric tally: BNTX 3 · LU 7It depends on what you're optimizing for:
GrowthBNTX(faster 5Y revenue CAGR)
QualityLU(higher ROIC)
Valuation
| Metric | BNTX | LU |
|---|---|---|
| P/S ratio | 6.97 | 0.09● |
| P/B ratio | 1.06 | 0.05● |
| EV / EBITDA | — | 72.98 |
| FCF yield | 6.53% | 312.50%● |
Profitability
| Metric | BNTX | LU |
|---|---|---|
| Gross margin | 73.26%● | 41.96% |
| Operating margin | -51.55% | -4.31%● |
| Net margin | -44.73% | -10.59%● |
| ROE | -6.79% | -4.14%● |
| ROIC | -3.14% | -0.21%● |
Growth (annualized)
| Metric | BNTX | LU |
|---|---|---|
| Revenue CAGR (5Y) | 2.16%● | -6.44% |
| EPS CAGR (5Y) | — | -43.16% |
| FCF CAGR (5Y) | — | 24.09% |
| Total return CAGR (5Y) | -17.39%● | -40.92% |
Frequently asked
- Which is better, BNTX or LU?
- It depends on your goal. growth: BNTX (faster 5Y revenue CAGR); quality: LU (higher ROIC). Across all compared metrics, LU leads 7 to 3.
- Which has grown faster, BNTX or LU?
- Over the past five years, BNTX grew revenue faster — BNTX at a 2.16% CAGR versus LU at -6.44%.
- Which has been the better investment, BNTX or LU?
- Over the past 5-year, BNTX delivered the higher annualized total return — BNTX at -17.39% versus LU at -40.92%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
BioNTech SE P/E ratioLufax P/E ratioBioNTech SE dividend yieldLufax dividend yieldBioNTech SE ROELufax ROEBioNTech SE operating marginLufax operating marginBioNTech SE revenue growthLufax revenue growthBioNTech SE free cash flowLufax free cash flow
BioNTech SE & Lufax appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.